Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe

LEAWOOD, Kan., Nov. 10, 2017 -- (Healthcare Sales & Marketing Network) -- Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY) and Aratana Therapeutics, Inc. (NASDAQ: PETX), today announced the European Medicine Agency's (EMA) Committee f... Biopharmaceuticals, Regulatory Elanco Animal Health, Eli Lilly, Aratana Therapeutics, GALLIPRANT, arthritis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news